Media coverage about ContraFect Corporation (NASDAQ:CFRX) has been trending somewhat positive recently, Accern reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. ContraFect Corporation earned a coverage optimism score of 0.07 on Accern’s scale. Accern also gave media headlines about the biotechnology company an impact score of 46.0631573316497 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.
Separately, Maxim Group reissued a “hold” rating on shares of ContraFect Corporation in a report on Thursday, May 25th.
Shares of ContraFect Corporation (NASDAQ CFRX) traded down 2.083% during midday trading on Friday, reaching $1.175. The company had a trading volume of 102,268 shares. The company’s market capitalization is $86.55 million. ContraFect Corporation has a 12 month low of $1.00 and a 12 month high of $3.28. The firm’s 50 day moving average price is $1.31 and its 200-day moving average price is $1.59.
ContraFect Corporation (NASDAQ:CFRX) last announced its earnings results on Wednesday, August 9th. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.18) by $0.11. Analysts anticipate that ContraFect Corporation will post ($0.43) earnings per share for the current fiscal year.
In other ContraFect Corporation news, Director Sol J. Barer acquired 40,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 25th. The shares were acquired at an average cost of $1.24 per share, for a total transaction of $49,600.00. Following the completion of the acquisition, the director now directly owns 815,933 shares of the company’s stock, valued at approximately $1,011,756.92. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have bought 50,800 shares of company stock worth $62,992 over the last quarter. 9.30% of the stock is owned by company insiders.
COPYRIGHT VIOLATION WARNING: “ContraFect Corporation (CFRX) Earning Somewhat Positive Press Coverage, Accern Reports” was first reported by BBNS and is owned by of BBNS. If you are accessing this article on another domain, it was stolen and reposted in violation of international copyright & trademark law. The legal version of this article can be accessed at https://baseballnewssource.com/markets/contrafect-corporation-cfrx-earns-daily-media-sentiment-rating-of-0-07-updated/1410166.html.
Receive News & Ratings for ContraFect Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ContraFect Corporation and related companies with our FREE daily email newsletter.